Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

IgA cross-reactivity between a nuclear autoantigen and wheat proteins suggests molecular mimicry as a possible pathomechanism in celiac disease.

Natter S, Granditsch G, Reichel GL, Baghestanian M, Valent P, Elfman L, Grönlund H, Kraft D, Valenta R.

Eur J Immunol. 2001 Mar;31(3):918-28.

2.

Anti-gliadin antibodies in patients with celiac disease cross-react with enterocytes and human calreticulin.

Tucková L, Karská K, Walters JR, Michalak M, Rossmann P, Krupicková S, Verdu EF, Saalman R, Hanson LA, Tlaskalová-Hogenová H.

Clin Immunol Immunopathol. 1997 Dec;85(3):289-96.

PMID:
9400629
3.

Serologic markers of untreated celiac disease in Libyan children: antigliadin, antitransglutaminase, antiendomysial, and anticalreticulin antibodies.

Ashabani A, Errabtea H, Shapan A, Tuckova L, Tlaskalova-Hogenova H.

J Pediatr Gastroenterol Nutr. 2001 Sep;33(3):276-82.

PMID:
11593122
4.

Identification of tissue transglutaminase as the autoantigen of celiac disease.

Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D.

Nat Med. 1997 Jul;3(7):797-801.

PMID:
9212111
5.

Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.

Stenman SM, Lindfors K, Korponay-Szabo IR, Lohi O, Saavalainen P, Partanen J, Haimila K, Wieser H, Mäki M, Kaukinen K.

BMC Immunol. 2008 Feb 29;9:6. doi: 10.1186/1471-2172-9-6.

6.

Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay.

Mankaï A, Sakly W, Landolsi H, Gueddah L, Sriha B, Ayadi A, Sfar MT, Skandrani K, Harbi A, Essoussi AS, Korbi S, Fabien N, Jeddi M, Ghedira I.

Pathol Biol (Paris). 2005 May;53(4):204-9.

PMID:
15850953
7.

Increased levels of IgA antibodies against desmin in children with coeliac disease.

Teesalu K, Uibo O, Kalkkinen N, Janmey P, Uibo R.

Int Arch Allergy Immunol. 2001 Oct;126(2):157-66.

PMID:
11729354
8.

Calreticulin--the potential autoantigen in celiac disease.

Karská K, Tucková L, Steiner L, Tlaskalová-Hogenová H, Michalak M.

Biochem Biophys Res Commun. 1995 Apr 17;209(2):597-605.

PMID:
7733929
9.

A novel method for detecting IgA endomysial antibodies by using human umbilical vein endothelial cells.

Castellino F, Scaglione N, Grosso SB, Sategna-Guidetti C.

Eur J Gastroenterol Hepatol. 2000 Jan;12(1):45-9.

PMID:
10656209
10.

Macroamylasemia attributable to gluten-related amylase autoantibodies: a case report.

Barera G, Bazzigaluppi E, Viscardi M, Renzetti F, Bianchi C, Chiumello G, Bosi E.

Pediatrics. 2001 Jun;107(6):E93.

PMID:
11389291
11.

Transglutaminase treatment of wheat and maize prolamins of bread increases the serum IgA reactivity of celiac disease patients.

Cabrera-Chávez F, Rouzaud-Sández O, Sotelo-Cruz N, Calderón de la Barca AM.

J Agric Food Chem. 2008 Feb 27;56(4):1387-91. doi: 10.1021/jf0724163.

PMID:
18193828
12.

Endomysium: autoantigen in coeliac disease.

Feighery C, Whelan A, Weir DG.

Eur J Gastroenterol Hepatol. 1997 Jul;9(7):655-6. Review.

PMID:
9262971
13.

[Relevance of anti-tissue transglutaminase antibodies in coeliac disease diagnosis].

Lepers S, Soula F, Fily S, Fontaine E, Vuye S, Colombel JF, Guimber D, Prin L, Dubucquoi S.

Ann Biol Clin (Paris). 2003 May-Jun;61(3):337-43. French.

14.

Autoantibodies in celiac disease: importance of fibroblasts.

Sulkanen S, Halttunen T, Marttinen A, Leivo EL, Laurila K, Mäki M.

J Pediatr Gastroenterol Nutr. 1998 Aug;27(2):206-13.

PMID:
9702655
15.

Tissue transglutaminase in celiac disease: role of autoantibodies.

Caputo I, Barone MV, Martucciello S, Lepretti M, Esposito C.

Amino Acids. 2009 Apr;36(4):693-9. doi: 10.1007/s00726-008-0120-z. Review.

PMID:
18600381
16.

Autoantibodies to tissue transglutaminase as predictors of celiac disease.

Dieterich W, Laag E, Schöpper H, Volta U, Ferguson A, Gillett H, Riecken EO, Schuppan D.

Gastroenterology. 1998 Dec;115(6):1317-21.

PMID:
9834256
17.

[Usefulness of anti-transglutaminase antibodies in the diagnosis of celiac disease].

Fernández ML, Vivas S, Ruiz de Morales JM, Marugán JM.

Gastroenterol Hepatol. 2005 Oct;28(8):437-40. Spanish.

PMID:
16185576
18.

Celiac disease: risk assessment, diagnosis, and monitoring.

Setty M, Hormaza L, Guandalini S.

Mol Diagn Ther. 2008;12(5):289-98. Review.

PMID:
18803427
19.

Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease.

Koskinen O, Collin P, Korponay-Szabo I, Salmi T, Iltanen S, Haimila K, Partanen J, Mäki M, Kaukinen K.

J Pediatr Gastroenterol Nutr. 2008 Oct;47(4):436-42. doi: 10.1097/MPG.0b013e31817b6dec.

PMID:
18852635
20.

Autoantibodies against soluble and immobilized human recombinant tissue transglutaminase in children with celiac disease.

Agardh D, Dahlbom I, Daniels T, Lörinc E, Ivarsson SA, Lernmark A, Hansson T.

J Pediatr Gastroenterol Nutr. 2005 Sep;41(3):322-7.

PMID:
16131987

Supplemental Content

Support Center